(Q45859973)

17 December 2017

title

Effect of FK 506 on Epstein-Barr virus specific cytotoxic T cells (English)

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

3 November 2022

0 references

0 references

K. Burman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703259

3 November 2022

D. H. Crawford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703259

3 November 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

17 December 2017

2 February 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1703259

full work available at URL

3 November 2022

https://api.elsevier.com/content/article/PII:0140673691909055?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

https://api.elsevier.com/content/article/PII:0140673691909055?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

3 November 2022

1 reference

17 December 2017

volume

337

1 reference

17 December 2017

issue

8736

1 reference

17 December 2017

page(s)

297-298

1 reference

17 December 2017

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

3 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

FK-506--how much potential?

3 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

3 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90905-5

3 November 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017